Chibret

Chibret was a prominent French pharmaceutical company dedicated to the field of ophthalmology. Established by the Chibret family in Clermont-Ferrand, the company gained international recognition for its innovation in eye care, including the development of specialized eye drops and ointments. In 1969, the company was acquired by Merck & Co. (MSD), becoming MSD-Chibret and serving as Merck's global center for ophthalmic research for several decades. The company was instrumental in launching landmark treatments such as Timoptol for glaucoma and various anti-inflammatory ophthalmic solutions. While the Chibret brand has been largely integrated into MSD's broader portfolio, its historical impact on the industry remains profound. The legacy of the founding family continues today through Laboratoires Théa, an independent ophthalmology company founded by Henri Chibret in 1994.